Not Yet RecruitingPhase 2ACTRN12607000228482

The antioxidant and immunomodulatory effects of a Marinova seaweed extract on healthy individuals

Participant: Healthy individuals Intervention: Seaweed extract Comparator: Dose comparison Outcome: In vivo changes in lymphocyte subsets and ex vivo changes in lymphocyte activation, phagocytosis of granulocytes and monocytes, and T helper1/T helper 2 cytokines.

Sponsor

Marinova Pty Ltd

Enrollment

10 participants

Start Date

Jul 2, 2007

Study Type

Interventional

Conditions

Antioxidant and immune cell function

Summary

The purpose of the study is to determine the effects of a natural medicine formulation on antioxidant and immune cell function. The study hypothesises that the oral administration of the study medication over 4 weeks will result in a statistically significant lowering of fasting laboratory values of immune cell function, compared with baseline levels.

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study examines whether a Marinova seaweed extract has antioxidant and immune-boosting effects in healthy people. It is open to healthy adults aged 18 to 65 who are willing to stop most medications during the study. Participants take the seaweed supplement and have blood tests to measure changes in their immune and antioxidant markers.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Seaweed extract taken from marine microalgae, Five of the participants will take two 500mg capsules of the study medication and five will take one 100mg capsule daily, with food. The study will continue for 28 days after the initial screening visit, measurement points will be at screening, day1, day 3 and week 4.

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000228482